Showing results (51-60 of 681) with videos related to
Sort By:
Pageof 69
The American Surgeon|April 1, 1998
Long-term survival after locally aggressive anorectal melanomaB P Whooley, P Shaw, A B Astrow, et al.Cancer|February 1, 1977
A new approach in specific, active immunotherapyM K Wallack, Z Steplewski, H Koprowski, et al.Annals of the Royal College of Surgeons of England|November 23, 2021
Idiopathic granulomatous mastitis: experience at a New York hospitalP Bhattarai, A Srinivasan, C D Valenzuela, et al.Diseases of the Colon and Rectum|March 1, 1997
Use of epidural anesthesia and spontaneous ventilation during transabdominal colon and rectal procedures in selected high-risk patient groupsA R Kolker, C J Hirsch, B S Gingold, et al.Journal of the American College of Surgeons|March 1, 1997
The role of cholecystectomy in acquired immunodeficiency syndromeD R Flum, S D Steinberg, A Y Sarkis, et al.American Journal of Clinical Oncology|June 17, 2000
Recurrent malignant chondroid syringoma of the foot: a case report and review of the literatureM D Barnett, M K Wallack, A Zuretti, et al.Journal of Biological Response Modifiers|January 1, 1983
A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatmentM K Wallack, M Meyer, A Bourgoin, et al.American Journal of Surgery|March 1, 1976
Bilateral adrenalectomy in treatment of disseminated breast cancerD L Galbut, M K Wallack, A S Brown, et al.The Journal of Surgical Research|December 1, 1988
Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2Y Barnavon, H Iwaki, J A Bash, et al.The American Surgeon|March 1, 1986
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO)M K Wallack, K McNally, M Michaelides, et al.Pageof 69